These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1359633)

  • 1. Gender differences in tardive dyskinesia: a critical review of the literature.
    Yassa R; Jeste DV
    Schizophr Bull; 1992; 18(4):701-15. PubMed ID: 1359633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
    Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
    Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 10-year follow-up study of tardive dyskinesia.
    Yassa R; Nair NP
    Acta Psychiatr Scand; 1992 Oct; 86(4):262-6. PubMed ID: 1360742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
    Kasper S; Lowry AJ; Hodge A; Bitter I; Dossenbach M
    Schizophr Res; 2006 Jan; 81(2-3):139-43. PubMed ID: 16253478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service.
    Lauterbach EC; Carter WG; Rathke KM; Thomas BH; Shillcutt SD; Vogel RL; Moore NC; Mimbs JW; Nelson WH
    Schizophr Bull; 2001; 27(4):601-13. PubMed ID: 11824487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa.
    Patterson BD; Swingler D; Willows S
    Schizophr Res; 2005 Jul; 76(1):89-97. PubMed ID: 15927802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of tardive dyskinesia in Japan.
    Inada T; Ohnishi K; Kamisada M; Matsuda G; Tajima O; Yanagisawa Y; Hashiguchi K; Shima S; Oh-e Y; Masuda Y
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(4-5):250-4. PubMed ID: 1675874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum creatine phosphokinase elevations in patients with tardive dyskinesia.
    Egan MF; Dargham AA; Kirch DG; Wyatt RJ
    Br J Psychiatry; 1993 Apr; 162():551-3. PubMed ID: 8097656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.
    Dixon L; Weiden PJ; Haas G; Sweeney J; Frances AJ
    Compr Psychiatry; 1992; 33(2):121-2. PubMed ID: 1347498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia in northern Israel: preliminary study.
    Schwartz M; Silver H; Tal I; Sharf B
    Eur Neurol; 1993; 33(3):264-6. PubMed ID: 8096816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia among Chinese and Malay patients with schizophrenia.
    Chong SA; Mahendran R; Machin D; Chua HC; Parker G; Kane J
    J Clin Psychopharmacol; 2002 Feb; 22(1):26-30. PubMed ID: 11799339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial.
    Diehl A; Reinhard I; Schmitt A; Mann K; Gattaz WF
    Eur Psychiatry; 2009 Jan; 24(1):33-40. PubMed ID: 18774276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia: prevalence, incidence, and risk factors.
    Kane JM; Woerner M; Lieberman J
    Psychopharmacology Suppl; 1985; 2():72-8. PubMed ID: 2860662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tardive dyskinesia in India: a prevalence study.
    Doongaji DR; Jeste DV; Jape NM; Sheth AS; Apte JS; Vahia VN; Desai AB; Vahora SA; Thatte S; Vevaina T; Bharadwaj J
    J Clin Psychopharmacol; 1982 Oct; 2(5):341-4. PubMed ID: 6127352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.